Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelogenous Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00069992 Information provided by National Cancer Institute (NCI)

First Received: October 3, 2003 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)